From Cytokinetics, Defying the Fashion in Biotech, Sticks with Gradual Science-Based Strategy:

rblum

rblum—

Robert Blum is CEO of South San Francisco-based Cytokinetics

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
IBM Watson Health Data in Action – Epidemiology Studies
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
IBM Watson

Sponsored · Whitepaper
What’s Next in Neuroscience Therapies
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

Sponsored · Whitepaper
What to Include in Your Life Sciences Company Fundraising Pitch Deck
What the most successful life sciences fundraising pitch decks all have in common
Brex

Xconomy on Demand

We offer a number of ways to subscribe for free!